Around 40 years ago evidence was increasingly coming to light of a cohort of individuals diagnosed with non-insulin dependent diabetes who, despite possessing islet cell autoantibodies, had maintenance of beta-cell function and so – at the time of diagnosis – did not require treatment with insulin.1
Although these individuals were usually over the age of 35 years and did not present with ketosis (suggesting that they did not have type 1 diabetes), they were typically not obese and lacked the features of metabolic syndrome (as expected in the classical picture of type 2 diabetes).
Furthermore, this group of patients with islet cell autoantibodies – and notably elevated levels of anti-GAD antibody (Box 1) – gradually progressed from treatment of hyperglycaemia with diet and oral hypoglycaemic agents to developing an absolute need for insulin – as expected with type 1 diabetes.2
As a consequence, the term latent autoimmune disease in adults (LADA) was introduced to describe the profile displayed by these individuals.3
Please login or register to read the rest of the article and to have access to downloads and comments.